Alimera Sciences (ALIM) Receives Positive ACD from NICE on ILUVIEN as DME Treatment
Tweet Send to a Friend
Alimera Sciences, Inc. (Nasdaq: ALIM) announced that the Appraisal Committee of the United Kingdom's National Institute for Health and Care ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
